In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik ...More

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India. ...Less

Putin's speech at an economic forum in St. Petersburg came less than two weeks before his summit with Uni ...More

Putin's speech at an economic forum in St. Petersburg came less than two weeks before his summit with United States President Joe Biden. U.S. and Russian officials said the agenda of the June 16 meeting in Geneva will likely include climate change and efforts to counter the coronavirus among other issues. ...Less

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Ga ...More

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results. ...Less

EpiVacCorona, which is being developed by Siberia’s Vector Institute, was authorized this month to carry ...More

EpiVacCorona, which is being developed by Siberia’s Vector Institute, was authorized this month to carry out trials on 150 volunteers over 60 and 3,000 volunteers over 18, the watchdog has said. ...Less

Despite the soaring infections, Russian President Vladimir Putin told Russia's top business association l ...More

Despite the soaring infections, Russian President Vladimir Putin told Russia's top business association last week that authorities are not planning any lockdowns or other additional restrictions. Moreover, the government lifted the seven-day self-isolation restrictions for those who come into contact with COVID-19 patients. ...Less

Kirill Dmitriev, head of the RDIF sovereign wealth fund, said Russia had already received requests from m ...More

Kirill Dmitriev, head of the RDIF sovereign wealth fund, said Russia had already received requests from more than 20 countries for 1 billion doses of its newly-registered COVID-19 vaccine. ...Less

The vaccine will be ready for wide distribution late this year or early next, officials say. That's rough ...More

The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China. Initial results from final-stage studies won’t be ready until November, with full data expected next year. ...Less

Last week, Russia became the first country in the world to license a coronavirus vaccine when President V ...More

Last week, Russia became the first country in the world to license a coronavirus vaccine when President Vladimir Putin announced its approval. But the vaccine has not yet passed the advanced trials normally required to prove it works before being licensed, a major breach of scientific protocol. ...Less

Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent week ...More

Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine. ...Less

Iran, which is fighting the Middle East's deadliest outbreak, has said it will only rely on vaccines made ...More

Iran, which is fighting the Middle East's deadliest outbreak, has said it will only rely on vaccines made by Russia, India or China, while also working to produce a homemade jab. ...Less

"Study results have demonstrated the effectiveness of the vaccine in triggering a strong antibody respons ...More

"Study results have demonstrated the effectiveness of the vaccine in triggering a strong antibody response against the virus, its safety for use, and its compliance with international safety and effectiveness standards," the statement said. ...Less

Researchers say based on their trial, which involved about 20,000 people in Russia last fall, the vaccine ...More

Researchers say based on their trial, which involved about 20,000 people in Russia last fall, the vaccine is about 91 per cent effective and that the shot also appeared to prevent people from becoming severely ill with COVID-19. The study was published online Tuesday in the journal, Lancet. ...Less

‘ The Russian vaccine is not an approved vaccine and hardly any trials have taken place.’ ...More

‘ The Russian vaccine is not an approved vaccine and hardly any trials have taken place.’ ...Less

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, t ...More

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa. ...Less

The US and other superpowers have laid claim to billions of Covid vaccine doses that are nearing the fini ...More

The US and other superpowers have laid claim to billions of Covid vaccine doses that are nearing the finish line. That’s sparked worries that poorer countries will be left behind and shots will be slow to reach many of them. Dozens of laboratories, researchers and companies from Thailand to Nigeria are bootstrapping their own work on inoculations. ...Less

The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a stateme ...More

The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a statement it partnered with the Virchow Group to produce up to 200 million doses of Sputnik a year in India. ...Less

Speaking at a government meeting on Tuesday, Vladimir Putin said that the vaccine has proven efficient du ...More

Speaking at a government meeting on Tuesday, Vladimir Putin said that the vaccine has proven efficient during tests, offering a lasting immunity from the coronavirus. ...Less

Russia faced international criticism for approving a vaccine that hasn't completed advanced trials among ...More

Russia faced international criticism for approving a vaccine that hasn't completed advanced trials among tens of thousands of people, and experts both at home and abroad warned against its wider use until the studies are completed. ...Less

"Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a ...More

"Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a WhatsApp text message. ...Less

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along w ...More

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not been tested in Phase 3 or larger clinical trials. ...Less

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states dir ...More

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V," the vaccine developers wrote on the official Sputnik V Twitter account. "Her comments raise serious questions about possible political interference in the ongoing EMA review," they said. ...Less

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health mi ...More

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. ...Less

An official at the RDIF, which markets the vaccine abroad, made the comments in a statement after some co ...More

An official at the RDIF, which markets the vaccine abroad, made the comments in a statement after some countries decided to widen the gap between the first and second doses of the vaccine developed in Russia. ...Less

Putin said Moscow was ready to cooperate with all other countries on coronavirus vaccines, but urged agai ...More

Putin said Moscow was ready to cooperate with all other countries on coronavirus vaccines, but urged against politicising the process, the day after vaccine developers Pfizer Inc and BioNTech said their experimental COVID-19 vaccine was more than 90% effective. ...Less

Lauding Russia for the vaccine, Raut, in his weekly column 'Rokhtokh' in the Shiv Sena mouthpiece 'Saaman ...More

Lauding Russia for the vaccine, Raut, in his weekly column 'Rokhtokh' in the Shiv Sena mouthpiece 'Saamana', said this was a sign of being a superpower, and added that Indian politicians will not follow Russia's example as a model since "they are in love with America". ...Less

The Russian Direct Investment Fund (RDIF), which has financed the development of the Sputnik V coronaviru ...More

The Russian Direct Investment Fund (RDIF), which has financed the development of the Sputnik V coronavirus vaccine, confirmed the figure to AFP without offering a breakdown of where the jab was distributed. ...Less

A source has said that several private hospitals have run out of the vaccine already. There have only bee ...More

A source has said that several private hospitals have run out of the vaccine already. There have only been a few lakh doses available in this country. ...Less

The Sputnik V and EMA teams held a scientific review of the vaccine on Tuesday, the Sputnik V account sai ...More

The Sputnik V and EMA teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. ...Less

"On Sputnik, we are still waiting, we are still in the back-and-forth stage. So we don't have a review me ...More

"On Sputnik, we are still waiting, we are still in the back-and-forth stage. So we don't have a review meeting scheduled yet," WHO spokeswoman Margaret Harris told a briefing in Geneva. ...Less

Putin also proposed that the creation of a vaccine research centre for BRICS countries - Brazil, Russia, ...More

Putin also proposed that the creation of a vaccine research centre for BRICS countries - Brazil, Russia, India, China and South Africa - be sped up, TASS reported. ...Less

RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in diffe ...More

RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba, according to the statement. ...Less

As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the va ...More

As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year. ...Less

An EU official who negotiates with vaccine makers on behalf of the bloc told Reuters that EU governments ...More

An EU official who negotiates with vaccine makers on behalf of the bloc told Reuters that EU governments were considering launching talks with Sputnik V developers and it would take requests from four EU states to start the process. ...Less

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along wi ...More

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in Phase 3 or larger clinical trials. ...Less

As announced in April, the RDIF - which markets the vaccine internationally, and Panacea Biotech agreed t ...More

As announced in April, the RDIF - which markets the vaccine internationally, and Panacea Biotech agreed to produce 100 million doses per year of Sputnik V in India. The first batch of the COVID-19 vaccine produced at Panacea Biotech's facilities at Baddi in Himachal Pradesh will be shipped to Russia's Gamaleya Center for quality control. ...Less

The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute i ...More

The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stages of development and is about to pass state registration, officials said. "We are very much counting on starting mass production in September," Industry Minister Denis Manturov said. ...Less

The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 vol ...More

The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said. ...Less

Countries in the region have been particularly hard hit by the virus and find themselves torn between a r ...More

Countries in the region have been particularly hard hit by the virus and find themselves torn between a readily available jab from their old ally and European Union resistance to Russian influence. ...Less